欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33873 篇 当前为第 192 页 共 3388

所属行业:医药制造业

  • 1911.全球肿瘤学市场中放射治疗分析和预测(2021-2031年)

    [医药制造业,科学研究和技术服务业] [2021-10-30]

    Currently, the field of radiation therapy is changing in terms of radiation type, and there are several changes in adoption patterns among its end-user segments. The end users are shifting from conventional radiation (Xray, or Cobalt-60, among others) to modern radiation such as a proton or heavy ion radiation. The increasing demand for modern radiation therapy systems has led to the increasing awareness of cancer/tumor treatments. The primary role of these systems is to shrink or destroy cancer/tumor depending on cancer/tumor type, stage, patient age, number of radiation sessions required, and many other factors. Radiation therapy can be divided primarily into external beam radiation therapy, also known as teletherapy, and internal beam radiation therapy, also known as brachytherapy. In the past decade, the definition of these technologies has expanded. Earlier the radiation therapy was only referred to as a simple therapy only done by the radiation beam. Now, radiation therapy includes internal radiation or external radiation combined with chemotherapy or open body surgery or combining various radiation therapy techniques such as IGRT, VMAT, and SRS to destroy or shrink cancer/ tumor. The ongoing trend of offering new radiation therapy systems which have proton or heavy ion beam, integration of two different radiation therapies, and integration of imaging technology with radiation therapy systems showcase the growing future of technological innovations and advancements in radiation therapy in the oncology field.

    关键词:放射治疗领域;传统辐射;X 射线;Cobalt-60;现代辐射;现代放射治疗系统;癌症/肿瘤;不断提高治疗
  • 1912.全球顶级健康由数字能力推动的创新行业问题2021年

    [医药制造业,金融业,信息传输、软件和信息技术服务业] [2021-10-30]

    Practically overnight, clinicians, healthcare providers, pharmaceutical companies and payers shifted much of their work onto virtual platforms and other digital technologies. As consumers grappled with a deadly new virus, providers embraced virtual technology in unprecedented numbers so they could continue to serve patients despite restrictions on in-person interactions. In doing so, they packed a decade’s worth of reforms into a few short months. Players across the industry boosted data analytics capabilities to respond to ongoing shifts in healthcare needs, consumer behaviour and the economy. The deployment of digital tools in clinical trials helped companies quickly test whether existing medicines worked against the new virus and enabled the rapid development of COVID-19 vaccines. And work began to shore up the weaknesses evident in the healthcare supply chain. All this took place amid the broader backdrop of changes coursing through the industry and a set of long-standing common issues affecting the health ecosystem. In the years before the pandemic, and in the months since COVID-19 altered the course of history, a series of transformations has been altering traditional paradigms. And they will continue to do so in coming years. These include a heightened focus on well-being and prevention, the push to develop cures in addition to treatments, paying based on outcomes rather than fee-for-service, new developments in gene therapy and precision medicine, cross-industry convergence, and an end-to-end focus on patient and clinician experience. These themes intersect and interact with significant issues, including excessive cost; health inequities; inadequate transparency, interoperability and collaboration; and a general lack of trust.

    关键词:临床医生;医疗保健提供者;制药公司;虚拟平台;数字技术;医疗保健供应链
  • 1913.全球手术器械跟踪设备市场分析(2021-2031年)

    [仪器仪表制造业,专用设备制造业,医药制造业] [2021-10-30]

    The global surgical instrument tracking devices market is expected to grow at a CAGR of 9.16% for the forecast period 2021-2031. Leading market players strive to retain a competitive edge by having a good presence in key markets and offering a diverse product range. The market has witnessed a total of 32 key developments over the five years (January 2016-March 2021), with a majority of them being product offerings and upgradation accompanied by partnerships, alliances, and business expansions. Efforts are being made to bring more technologically innovative goods to market, each aimed at a particular unmet need. With the launch of new and updated devices with improved features, surgical instrument tracking devices technology has become increasingly possible to unlock new use cases.

    关键词:全球手术器械跟踪设备;复合年增长率;技术创新
  • 1914.全球直接面向消费者的基因检测市场分析和预测(2021-2031年)

    [医药制造业,科学研究和技术服务业] [2021-10-29]

    Direct-to-consumer genetic tests (DTC-GT) offers its consumers the ability to solve their individual genetic puzzle. The confluence of breakthroughs in genetic testing has not only decreased the time required to perform a genetic test but also has reduced the cost of conducting these tests. All these factors combined have given DTC-GT a lot of acceptance among the consumers. The major proponent of the DTC-GT market is the distribution channels opted by the companies. The companies are marketing these tests via online or retail channels. With the piqued advertisements of these tests through print, media, and the internet, the industry is gaining familiarity among consumers. Companies such as 23andme, Mapmygenome, Ancestry.com, EasyDNA, and 24Genetic are offering a large number of diversified services related to genealogy testing, health conditions, and traits. The journey of the DTC-GT initiates by a consumer ordering the test through an online channel. The sample collection kit is provided to the consumers. DNA sample such as saliva or oral swab is collected by the consumer and sent back to the organization for the analysis. Consumers get their test results on their online account within 3-5 weeks.

    关键词:直接面向消费者的基因检测 (DTC-GT) ;遗传谜题;基因检测;降低测试成本;DTC-GT
  • 1915.全球心电图市场分析与预测(2021-2031年)

    [医药制造业,计算机、通信和其他电子设备制造业] [2021-10-29]

    The Food and Drug Administration (FDA) regulates medical devices in the U.S. to ensure their effectiveness and safety for patients and users. The FDA's Center for Devices and Radiological Health (CDRH) oversees regulating these firms. The FDA must approve every company involved in the manufacturing, packaging, labeling, and/or sale of medical devices sold in the U.S. Electrocardiographs are classified into Class II categories of medical devices in the U.S. These systems are considered as medical devices through the Federal Food, Drug and Cosmetic (FD&C) Act. Diagnostic imaging systems are classified under the category of non-501(k)-exempt Class I and Class II medical devices and do not follow the Pre-Marketing Approval (PMA) pathway by U.S. Food and Drug Administration (FDA). In 501(k) pathways, any new diagnostic imaging devices under Class I and Class II should be legally marketed and should have a clear definition of technological characteristics, applications, and indications.

    关键词:美国食品和药物管理局 (FDA) ;医疗器械;有效性和安全性;FDA 设备;放射中心 Health (CDRH) ;心电图仪; II 类医疗器械;医疗设备;断成像系统
  • 1916.集采承压之下 蓝帆医疗重组心脑血管业务

    [医药制造业,专用设备制造业] [2021-10-28]

    关键词:集采;蓝帆医疗;心脑血管业务;心脏支架
  • 1917.我国宫颈癌疫苗获世卫组织认证

    [医药制造业] [2021-10-27]

    关键词:宫颈癌疫苗;世卫组织认证
  • 1918.全球血液动力学监测设备市场(2021-2030年)

    [电气机械和器材制造业,医药制造业,专用设备制造业] [2021-10-27]

    The scope of the research study titled global hemodynamic monitoring devices market is aimed at assessing the market potential of various hemodynamic monitoring devices. The following were the types of approaches in which the global hemodynamic monitoring devices market was estimated and its growth potential for the forecast period was evaluated:

    关键词:全球血流动力学;监测设备;市场潜力;增长潜力
  • 1919.全球肝素市场报告(2021-2028年)

    [医药制造业] [2021-10-27]

    Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. Heparin is used to prevent formation of blood clots caused by certain medical conditions or medical procedures. The report provides market dynamics and trends related to the global heparin market. The study estimates the revenue generated from the sales of heparin products; however, it excludes the heparin products service revenue. The valuations comprise revenue generated from heparin products such as unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin.

    关键词:肝素;抗凝药物;嗜碱性粒细胞;天然糖胺聚糖;肥大细胞;医疗程序
  • 1920.全球健康保险市场(2021-2028年)

    [医药制造业,信息传输、软件和信息技术服务业] [2021-10-27]

    Health insurance covers medical expenses incurred during treatment of any disease, injury, or other mental & physical impairment. It acts as compensation in exchange for a monthly/semi-annual/annual premium or a payroll tax to provide healthcare benefits. The insurer is obliged to cover medical expenses for the policy holder up till the tenure and coverage of the policy. Depending on the policy, the coverage may vary for numerous factors, including diseases, age group, government policies, and others.

    关键词:健康保险;任何疾病;伤害;医疗费用;身体障碍;医疗福利;医疗费用
首页  上一页  ...  187  188  189  190  191  192  193  194  195  196  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服